May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Helmerich and Payne, J B Hunt Transport Services and
Stratasys, on Tuesday.
HIGHLIGHTS
* Helmerich and Payne Inc HP.N : Zephirin Group raises price objective to $52 from $42
* J B Hunt Transport Services Inc JBHT.O : Benchmark starts with buy rating
* Stratasys Ltd SSYS.O : JP Morgan raises to neutral from underweight
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
* Alexandria Real Estate Equities ARE.N : JP Morgan cuts target price to $203 from $219
* American Well Corp AMWL.N : Piper Sandler cuts target price to $5 from $7
* Aspen Technology Inc AZPN.O : Piper Sandler cuts target price to $159 from $170
* Autodesk Inc ADSK.O : Credit Suisse cuts target price to $355 from $440
* Baker Hughes Co BKR.O : Zephirin Group raises price objective to $37.50 from $28
* Century Therapeutics Inc IPSC.O : JP Morgan cuts target price to $34 from $40
* Century Therapeutics Inc IPSC.O : Piper Sandler cuts target price to $22 from $38
* Chimerix Inc CMRX.O : H.C. Wainwright cuts target price to $11 from $24
* Chromadex Corp CDXC.O : Oppenheimer cuts target price to $7 from $17
* Clarus Therapeutics Holdings Inc CRXT.O : Truist Securities cuts PT to $3 from $7
* Clean Energy Fuels Corp CLNE.O : Credit Suisse cuts target price to $12.50 from $16
* Diamondback Energy Inc FANG.O : Wells Fargo cuts target price to $200 from $204
* Fathom Digital Manufacturing Corp FATH.N : Craig-Hallum cuts target price to $9 from $11
* Gilead Sciences Inc GILD.O : Piper Sandler cuts target price to $69 from $73
* Halliburton Co HAL.N : Zephirin Group raises price objective to $45 from $38
* Helmerich and Payne Inc HP.N : Zephirin Group raises price objective to $52 from $42
* J B Hunt Transport Services Inc JBHT.O : Benchmark starts with buy rating
* J B Hunt Transport Services Inc JBHT.O : Benchmark starts with $215 price target
* Jones Lang LaSalle Inc JLL.N : KBW cuts target price to $225 from $270
* Novanta Inc NOVT.O : Berenberg cuts target price to $120 from $135
* Passage Bio Inc PASG.O : Raymond James cuts target price to $10 from $24
* Privia Health Group Inc PRVA.O : JP Morgan cuts target price to $40 from $45
* Scholar Rock Holding Corp SRRK.O : Piper Sandler cuts target price to $28 from $56
* scPharmaceuticals Inc SCPH.O : SVB Securities raises target price to $6 from $5
* Select Medical Holdings Corp SEM.N : Credit Suisse cuts target price to $27 from $28
* Shoals Technologies Group Inc SHLS.O : JP Morgan cuts target price to $27 from $33
* Shoals Technologies Group Inc SHLS.O : Piper Sandler cuts target price to $15 from $16
* Spero Therapeutics Inc SPRO.O : Cantor Fitzgerald cuts target price to $5 from $27
* Stratasys Ltd SSYS.O : JP Morgan raises to neutral from underweight
* Stratasys Ltd SSYS.O : JP Morgan cuts target price to $23 from $25
* Syros Pharmaceuticals Inc SYRS.O : Alliance Global Partners cuts PT to $10 from $14
* Take-Two Interactive Software Inc TTWO.O : Credit Suisse cuts PT to $182 from $190
* Taysha Gene Therapies Inc TSHA.O : Needham cuts target price to $20 from $32
* Tidewater Inc TDW.N : Zephirin Group raises price objective to $27 from $15
* Weber Inc WEBR.N : JP Morgan cuts target price to $6.50 from $8.50
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))